Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants

NCT02209506 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

23

Enrollment

INDUSTRY

Sponsor class

Stopped Long-term animal toxicology findings (see detailed description).

Conditions

Safety
Tolerability
Pharmacokinetics
Pharmacodynamics

Interventions

DRUG: MLN3126
DRUG: MLN3126 Matched Placebo

Sponsor

Takeda